Celltrion Pharm Inc
068760
Company Profile
Business description
Celltrion Pharm Inc is active in the Korean healthcare sector. Its core business includes the manufacture and sale of pharmaceuticals such as heptatonic, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs and antibiotics.
Contact
17Floor, LG Dacom Building
706-1 Yeoksam-dong
Kangnamgu
Seoul130-987
KORT: +82 222163611
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,009
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,390.10 | 16.40 | 0.17% |
| CAC 40 | 8,225.73 | 19.66 | 0.24% |
| DAX 40 | 24,264.29 | 5.49 | 0.02% |
| Dow JONES (US) | 46,830.55 | 123.97 | 0.27% |
| FTSE 100 | 9,407.22 | 3.65 | 0.04% |
| HKSE | 26,027.55 | 168.72 | 0.65% |
| NASDAQ | 22,939.73 | 50.81 | -0.22% |
| Nikkei 225 | 49,316.06 | 130.56 | 0.27% |
| NZX 50 Index | 13,377.85 | 32.89 | 0.25% |
| S&P 500 | 6,732.13 | 3.00 | -0.04% |
| S&P/ASX 200 | 9,094.70 | 18.80 | 0.21% |
| SSE Composite Index | 3,916.33 | 52.44 | 1.36% |